Evidence map›Paper›PMID 22837074›Full record

ArticleCytometry. Part A : the journal of the International Society for Analytical Cytology2012

Image cytometry-based detection of aneuploidy by fluorescence in situ hybridization in suspension.

Hans Minderman, Kristen Humphrey, Jane K Arcadi, Andrzej Wierzbicki, Orla Maguire, Eunice S Wang, AnneMarie W Block, Sheila N J Sait, Thaddeus C George, Paul K Wallace

Open access · bronzeAbstract read
In one paragraph

Article in Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. "Immuno-FlowFISH": Applications for Chronic Lymphocytic Leukemia.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  3. Simultaneous Analysis of Phenotype and Cytogenetics Using Imaging Flow Cytometry: Time to Teach Old Dogs New Tricks.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2019
    Article
  4. Review
  5. Article
  6. Article
  7. Fluorescent In Situ Hybridization in Suspension by Imaging Flow Cytometry.Methods in molecular biology (Clifton, N.J.) · 2016
    Article
  8. Enhanced γ-H2AX DNA damage foci detection using multimagnification and extended depth of field in imaging flow cytometry.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2015
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Hans MindermanFlow and Image Cytometry Laboratory, Department of Pathology and Laboratory Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263, USA. hans.minderman@roswellpark.org
Kristen Humphrey
Jane K Arcadi
Andrzej Wierzbicki
Orla Maguire
Eunice S Wang
AnneMarie W Block
Sheila N J Sait
Thaddeus C George
Paul K Wallace
Roswell Park Comprehensive Cancer Center · USOmeros Corporation (United States) · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
Clinical application of multispectral imaging flow cytometryR33CA126667 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MINDERMAN, HANS · 2010 to 2011
$511k
A SHARED MULTIPARAMETER IMAGING CYTOMETERS10RR022335 · NCRR · ROSWELL PARK CANCER INSTITUTE CORP · PI WALLACE, PAUL K · 2006 to 2006
$293k
NCI NIH HHS 4R33CA126667NCI NIH HHS CA016056NCI NIH HHS P30 CA016056NCI NIH HHS R33 CA126667NCRR NIH HHS 1S10RR022335-01NCRR NIH HHS S10 RR022335
6 · The paper itself

Abstract

Cytogenetic abnormalities are important diagnostic and prognostic criteria for hematologic malignancies. Karyotyping and fluorescence in situ hybridization (FISH) are the conventional methods by which these abnormalities are detected. The sensitivity of these microscopy-based methods is limited by the abundance of the abnormal cells in the samples and therefore these analyses are commonly not applicable to minimal residual disease (MRD) stages. A flow cytometry-based imaging approach was developed to detect chromosomal abnormalities following FISH in suspension (FISH-IS), which enables the automated analysis of several log-magnitude higher number of cells compared with the microscopy-based approaches. This study demonstrates the applicability of FISH-IS for detecting numerical chromosome aberrations, establishes accuracy, and sensitivity of detection compared with conventional FISH, and feasibility to study procured clinical samples of acute myeloid leukemia (AML). Male and female healthy donor peripheral blood mononuclear cells hybridized with combinations of chromosome enumeration probes (CEP) 8, X, and Y served as models for disomy, monosomy, and trisomy. The sensitivity of detection of monosomies and trisomies amongst 20,000 analyzed cells was determined to be 1% with a high level of precision. A high correlation (R(2) = 0.99) with conventional FISH analysis was found based on the parallel analysis of diagnostic samples procured from 10 AML patients with trisomy 8 (+8). Additionally, FISH-IS analysis of samples procured at the time of clinical remission demonstrated the presence of residual +8 cells indicating that this approach may be used to detect MRD and associated chromosomal defects.

Indexed as

AneuploidyAlgorithmsFemaleFlow CytometryHumansImage Processing, Computer-AssistedIn Situ Hybridization, FluorescenceLeukemia, Myeloid, AcuteLeukocytes, MononuclearLimit of DetectionMaleModels, BiologicalReproducibility of ResultsSingle-Cell Analysis

Identifiers

PMID22837074
PMCPMC4384178
OpenAlexW2000384518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.